Skip to content

Bacopa monnieri vs Ginkgo biloba: what the evidence shows

Evidence last reviewed Editorial review: NootropicsWork Editorial TeamEducational, not medical advice

The two compounds

Bacopa monnieri

Herbal extract (Ayurvedic herb)

Ginkgo biloba

Botanical (leaf extract containing flavonol glycosides and terpene lactones)

Grades side by side

OutcomeBacopa monnieriGinkgo biloba
AttentionNot graded
Perceived stressNot graded
Processing speedNot graded
Executive functionNot graded
Acute cognitive performanceNot graded
Global cognitionNot graded
MemoryNot graded
Delayed recallNot graded

Bottom line

Bacopa is a plant used in Ayurvedic medicine [1], and Ginkgo biloba is a tree [2] whose leaf extract is used as a supplement [3]. In trials of about 12 weeks, bacopa extracts improved some memory tests, mainly free recall and delayed memory [4][5]. A ginkgo meta-analysis in healthy people found near-zero effects for memory, attention and executive function [6].

What the Bacopa monnieri page found

Bacopa monnieri is a plant used in Ayurvedic medicine [1]. In placebo-controlled trials lasting about 12 weeks, bacopa extracts improved some memory tests, mainly free recall and delayed memory, but other cognitive results were mixed [4][5]. Small single-dose trials gave inconsistent results [7][8]. Digestive side effects such as nausea and cramps were reported [9].

Read the full Bacopa monnieri evidence page for every graded outcome, the doses used in studies, safety and interactions.

What the Ginkgo biloba page found

Ginkgo biloba leaf extract is one of the most widely sold botanical supplements [3], but a meta-analysis of randomized trials in healthy people found effects close to zero for memory, attention and executive function [6], and a six-year trial in 3,069 older adults found no difference from placebo in cognitive change [10]. Regulators flag bleeding risk with blood thinners [11][12].

Read the full Ginkgo biloba evidence page for every graded outcome, the doses used in studies, safety and interactions.

How to read this comparison

The grades side by side come from each compound's own evidence page and change when either page is re-graded. A grade covers the people and doses in its studies, not every use. This page does not rank one compound above the other; check both safety sections before combining them.

References

  1. Gościniak A, Stasiłowicz-Krzemień A, Szeląg M, et al. Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability. Nutrients. 2025.PMID 40507208DOI 10.3390/nu17111939Tier 1, narrative review
  2. National Center for Complementary and Integrative Health (NIH). Ginkgo: Usefulness and Safety. 2025-02.SourceTier 2
  3. Mei N, Guo X, Ren Z, et al. Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2017.PMID 28055331DOI 10.1080/10590501.2016.1278298Tier 1, narrative review
  4. Pase MP, Kean J, Sarris J, et al. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials. J Altern Complement Med. 2012.PMID 22747190DOI 10.1089/acm.2011.0367Tier 1, systematic review
  5. Tiemtad P, Ingkaninan K, Temkitthawon P, et al. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis. Phytomedicine. 2026.PMID 41678913DOI 10.1016/j.phymed.2026.157915Tier 1, meta-analysis
  6. Laws KR, Sweetnam H, Kondel TK. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis. Hum Psychopharmacol. 2012.PMID 23001963DOI 10.1002/hup.2259Tier 1, meta-analysis
  7. Nathan PJ, Clarke J, Lloyd J, et al. The acute effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy normal subjects. Hum Psychopharmacol. 2001.PMID 12404571DOI 10.1002/hup.306Tier 1
  8. Benson S, Downey LA, Stough C, et al. An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood. Phytother Res. 2014.PMID 23788517DOI 10.1002/ptr.5029Tier 1, RCT
  9. Morgan A, Stevens J. Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. J Altern Complement Med. 2010.PMID 20590480DOI 10.1089/acm.2009.0342Tier 1, RCT
  10. Snitz BE, O'Meara ES, Carlson MC, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA. 2009.PMID 20040554DOI 10.1001/jama.2009.1913Tier 1, RCT
  11. Health Canada (Natural and Non-prescription Health Products Directorate). Ginkgo - Ginkgo biloba (NHPID monograph). Updated July 25, 2025.SourceTier 1
  12. European Medicines Agency (HMPC). Ginkgo folium - herbal medicinal product (summary for the public). Updated December 14, 2015.SourceTier 1
Reviewed by NootropicsWork Editorial Team, editorial team. Checklist logged . Next review due . Report an error